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Chiron/Cetius Research Project on Convertase Inhibitors 
Progress Report-June 21, 1992 
by James C. Powers 
Peptide Phosphonate Inhibitors 
The diesters of a-aminoalkylphosphonic acids are analogs of 
natural a-amino acids and are designated by the gen~rally accepted 
three letter abbreviations for the amino acid followed by the 
superscript P. For example diphenyl a-(N-
benzyloxycarbonylamino)ethylphosphonate which is related to 
alanine is abbreviated as Cbz-AlaP(OPh)2· 
CH3 
. I ~OPh 
Bzi-0-CO-NH-CH-P 
n'OPh 
Complete Structure of Cbz-AiaP (0Ph)2 
0 
The mechanism of inhibition of serine proteases involves 



















Properties of Peptide Phosophonates 
Stable in plasma for > 3 days 
Inhibited derivatives very stable 
Highly specific 
Irreversible inhibitors 
0 .. , ' , ' 
~ ~ oxyanion 
N N hole 
Sequence can be tailored to a specific serine protease 
October 1991 
Provided Cetus with the following phosphonates for testing. 
2.4 g Boc-Val-Pro-ValP(OPh)2 
2.7 g Boc-Ala-Pro-ValP(OPh)2 
1.1 g Boc-Ala-Gln-AlaP(OPh)2 
1.2 g Boc-Ala-Gln-AlaP(OPh)2 (different crystallization 
batch) 
0.5 g Boc-Leu-Ala-Gln-AlaP(OPh)2· 
March 1992 
Provided Cetus with small samples of the following phosphonates 
for testing. 
Boc-Val-Pro-ValP(QPh-4-Cl)2 
TFA salt of Val-Pro-ValP(OPh-4-Cl)2 
HCl salt of Val-Pro-ValP(OPh-4-Cl)2 
Z-Val-Pro-ValP(QPh-4-Cl)2 
and several other simple derivatives as negative controls 
These 4-chlorophenoxy derivatives should be more reactive than the 
corresponding phenoxy compounds. _ 
March 1992 
Provided Cetius with 
1 g of Boc-Ala-Pro-ValP(OPh)2 











phenylphosphinic acid analogs 
Z-ValP (OPh) (Ph) 
ValP (OPh) (Ph) 




Histidine Phosphonate Derivatives (April, May, and June 
1992) 
The route will involve synthesis of Im-CH2-CHO (Im = 
imidazole). This will be converted Z-HisP(OPh)2 and then 
eventually to Boc-Val-Pro-HisP(OPh)2· 
At present three separate routes for the synthesis of 
imidazole 4-acetaldehyde have been tried. They involved starting 
with histidine, histamine, imidazole ethanol, or imidazole acetic 
acid. We have been unable to obtain a significant yield of 
aldehyde. We are now planning alternate routes which involve 
addition/construction of the imidazole ring after the phosphonate 
is formed. 
